Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
Q1 FY2022
As of Jun 30, 2021
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowances of $1,355 and $1,230 as of March 31, 2026 and 2025, respectively
Inventories, net
Contract assets
Prepaid expenses and other current assets
Income tax receivable
Total current assets
Property, plant and equipment, net of depreciation and amortization of $81,934 and $75,773 as of March 31, 2026 and 2025, respectively
Goodwill
Intangible assets, net
Operating lease right-of-use assets
Deferred income taxes
Other non-current assets
Total assets
Liabilities and equity
Current liabilities:
Accounts payable
Accrued liabilities
Current portion of long-term debt
Borrowings under revolving credit facility
Contract liabilities
Lease liabilities
Income taxes payable
Total current liabilities
Borrowings under revolving credit facility
Long-term debt, net of current maturities and deferred debt issuance costs of $503 and $508 as of March 31, 2026 and 2025, respectively
Deferred income taxes
Non-current lease liabilities
Other non-current liabilities
Total liabilities
Equity
Common stock: $.001 par value; 150,000,000 authorized; 34,169,520 issued and 32,866,352 outstanding, and 33,945,413 shares issued and 33,243,370 outstanding at March 31, 2026 and 2025, respectively
Preferred stock: $.001 par value; 10,000,000 authorized; no shares issued and outstanding
Additional paid-in capital
Treasury stock, common stock, at cost; 1,303,168 and 702,043 shares at March 31, 2026 and 2025, respectively
Accumulated other comprehensive loss
Retained earnings
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support